Want to see HK:2410 full AI Analyst Report?
TYK Medicines, Inc. Class H (2410) Ratios
TYK Medicines, Inc. Class H Ratios
HK:2410's free cash flow for Q2 2026 was $-53.97M. For the 2026 fiscal year, HK:2410's free cash flow was decreased by $-8.34M and operating cash flow was $-45.63M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 |
|---|---|---|---|---|
| Liquidity Ratios | ||||
| Current Ratio | 1.43 | 1.97 | 0.18 | 0.29 |
| Quick Ratio | 1.43 | 1.97 | 0.18 | 0.29 |
| Cash Ratio | 1.19 | 1.51 | 0.14 | 0.09 |
| Solvency Ratio | -0.54 | -0.81 | -0.24 | -0.28 |
| Operating Cash Flow Ratio | -0.70 | -1.07 | -0.15 | -0.23 |
| Short-Term Operating Cash Flow Coverage | -1.61 | -2.14 | -0.16 | -8.34 |
| Net Current Asset Value | $ -51.90M | $ 125.84M | $ -1.22B | $ -784.38M |
| Leverage Ratios | ||||
| Debt-to-Assets Ratio | 0.20 | 0.19 | 2.32 | 0.15 |
| Debt-to-Equity Ratio | 0.53 | 0.38 | -1.36 | -0.16 |
| Debt-to-Capital Ratio | 0.35 | 0.27 | 3.76 | -0.19 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 2.72 | 1.95 | -0.59 | -1.10 |
| Debt Service Coverage Ratio | -1.95 | -2.21 | -0.26 | -6.58 |
| Interest Coverage Ratio | -21.62 | -25.20 | 0.00 | -13.02 |
| Debt to Market Cap | 0.03 | 0.01 | 0.28 | 0.01 |
| Interest Debt Per Share | 0.45 | 0.56 | 3.65 | 0.27 |
| Net Debt to EBITDA | 0.74 | 0.75 | -3.29 | 0.03 |
| Profitability Margins | ||||
| Gross Profit Margin | 0.00% | 13.08% | 0.00% | 45.30% |
| EBIT Margin | 0.00% | -350800.00% | 0.00% | -697.41% |
| EBITDA Margin | 0.00% | -323394.39% | 0.00% | -660.50% |
| Operating Profit Margin | 0.00% | -296072.90% | 0.00% | -530.70% |
| Pretax Profit Margin | 0.00% | -362549.53% | 0.00% | -704.76% |
| Net Profit Margin | 0.00% | -361640.19% | 0.00% | -702.94% |
| Continuous Operations Profit Margin | 0.00% | -362549.53% | 0.00% | -704.76% |
| Net Income Per EBT | 97.97% | 99.75% | 99.81% | 99.74% |
| EBT Per EBIT | 94.86% | 122.45% | 0.00% | 132.80% |
| Return on Assets (ROA) | -37.43% | -42.26% | -66.73% | -55.70% |
| Return on Equity (ROE) | -101.82% | -82.49% | 39.27% | 61.47% |
| Return on Capital Employed (ROCE) | -66.54% | -50.56% | 0.00% | 58.13% |
| Return on Invested Capital (ROIC) | -50.58% | -39.75% | 0.00% | 66.32% |
| Return on Tangible Assets | -40.37% | -46.71% | -84.76% | -72.54% |
| Earnings Yield | -6.62% | -2.59% | -8.31% | -6.93% |
| Efficiency Ratios | ||||
| Receivables Turnover | 0.00 | 0.03 | 0.00 | 23.84 |
| Payables Turnover | 0.54 | 0.00 | 0.00 | 2.50 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.33 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.08 |
| Working Capital Turnover Ratio | 0.00 | -0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -676.66 | -65249.24 | 0.00 | -130.45 |
| Days of Sales Outstanding | 0.00 | 11840.33 | 0.00 | 15.31 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 676.66 | 77089.57 | 0.00 | 145.76 |
| Operating Cycle | 0.00 | 11840.33 | 0.00 | 15.31 |
| Cash Flow Ratios | ||||
| Operating Cash Flow Per Share | -0.58 | -0.91 | -0.54 | -0.59 |
| Free Cash Flow Per Share | -0.68 | -1.13 | -0.75 | -0.83 |
| Dividend Paid and CapEx Coverage Ratio | -5.47 | -4.19 | -2.60 | -2.50 |
| Capital Expenditure Coverage Ratio | -5.47 | -4.19 | -2.60 | -2.50 |
| Operating Cash Flow Coverage Ratio | -1.41 | -1.74 | -0.15 | -2.67 |
| Operating Cash Flow to Sales Ratio | 0.00 | -2880.86 | 0.00 | -4.97 |
| Free Cash Flow Yield | -5.79% | -2.55% | -6.04% | -6.87% |
| Valuation Ratios | ||||
| Price-to-Earnings (P/E) Ratio | -15.10 | -38.64 | -12.04 | -14.42 |
| Price-to-Sales (P/S) Ratio | 0.00 | 139726.58 | 0.00 | 101.40 |
| Price-to-Book (P/B) Ratio | 15.38 | 31.87 | -4.73 | -8.87 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -17.28 | -39.15 | -16.55 | -14.55 |
| Price-to-Operating Cash Flow Ratio | -20.44 | -48.50 | -22.91 | -20.39 |
| Price-to-Earnings Growth (PEG) Ratio | 0.47 | -3.32 | -0.53 | 0.00 |
| Enterprise Value Multiple | -14.51 | -42.46 | -16.56 | -15.32 |
| Enterprise Value | 4.20B | 14.69B | 5.74B | 4.48B |
| EV to EBITDA | -14.51 | -42.46 | -16.56 | -15.32 |
| EV to Sales | 0.00 | 137309.62 | 0.00 | 101.21 |
| EV to Free Cash Flow | -16.44 | -38.47 | -20.65 | -14.53 |
| EV to Operating Cash Flow | -19.45 | -47.66 | -28.58 | -20.35 |
| Tangible Book Value Per Share | 0.61 | 1.14 | -2.70 | -1.70 |
| Shareholders’ Equity Per Share | 0.77 | 1.39 | -2.63 | -1.36 |
| Tax and Other Ratios | ||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.12 |
| Net Income Per Share | -0.78 | -1.15 | -1.03 | -0.84 |
| Tax Burden | 0.98 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 0.95 | 1.03 | 1.02 | 1.01 |
| Research & Development to Revenue | 0.00 | 2200.43 | 0.00 | 5.19 |
| SG&A to Revenue | 0.00 | 1012.45 | 0.00 | 0.25 |
| Stock-Based Compensation to Revenue | 0.00 | 116.51 | 0.00 | 0.00 |
| Income Quality | 0.71 | 0.79 | 0.52 | 0.71 |
Currency in CNY
